What Researchers Did
Researchers conducted a review to summarize the latest research on managing moderate-to-severe refractory Crohn's disease, focusing on current and emerging therapeutic modalities.
What They Found
The review identified strategies to manage refractory Crohn's disease, including early implementation and optimization of advanced therapies. It also explored emerging and alternative treatments such as fecal microbiota transplant, exclusive enteral feeding, hyperbaric oxygen, stem cell therapy, bone marrow transplant, and posaconazole.
What This Means for Canadian Patients
Canadian patients with refractory Crohn's disease may benefit from optimized current therapies and the exploration of emerging treatment options. This review highlights potential future directions in care that could improve quality of life and reduce disease burden.
Canadian Relevance
This study has no direct Canadian connection as it is a general review of global research on Crohn's disease management.
Study Limitations
As a review, this study's findings are dependent on the scope and quality of the existing literature it synthesized.